History | Cabozantinib for previously treated advanced renal cell carcinoma | Guidance | NICE

History

Documents created during the development process.

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 446 KB)

Published:

10 July 2017
Committee papers (PDF 1.15 MB)

Published:

10 July 2017
Public committee slides (PDF 448 KB)

Published:

10 July 2017

Draft guidance: 2

Draft guidance: 2
Appraisal consultation document (PDF 162 KB)

Published:

19 April 2017
Committee papers (PDF 6.07 MB)

Published:

19 April 2017
Public committee slides (PDF 905 KB)

Published:

19 April 2017

Draft guidance

Draft guidance
Appraisal consultation document (PDF 592 KB)

Published:

21 February 2017
Committee papers (PDF 11.88 MB)

Published:

06 March 2017
Public committee slides (PDF 1.43 MB)

Published:

06 March 2017

Invitation to participate

Equality Impact Assessment (Guidance development) (PDF 120 KB)

Published:

15 August 2016
Final scope updated September 2016 (PDF 166 KB)

Published:

15 September 2016
Final matrix updated September 2016 (PDF 98 KB)

Published:

15 September 2016
NICE's response to comments on the draft scope and provisional matrix (PDF 253 KB)

Published:

22 September 2016

Draft scope documents

Draft scope (pre-referral) (PDF 119 KB)

Published:

08 July 2016
Provisional matrix (pre-referral) (PDF 99 KB)

Published:

08 July 2016